Advances in sepsis biomarkers.
Adv Clin Chem
; 119: 117-166, 2024.
Article
en En
| MEDLINE
| ID: mdl-38514209
ABSTRACT
Sepsis, a dysregulated host immune response to an infectious agent, significantly increases morbidity and mortality for hospitalized patients worldwide. This chapter reviews (1) the basic principles of infectious diseases, pathophysiology and current definition of sepsis, (2) established sepsis biomarkers such lactate, procalcitonin and C-reactive protein, (3) novel, newly regulatory-cleared/approved biomarkers, such as assays that evaluate white blood cell properties and immune response molecules, and (4) emerging biomarkers and biomarker panels to highlight future directions and opportunities in the diagnosis and management of sepsis.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Sepsis
Límite:
Humans
Idioma:
En
Revista:
Adv Clin Chem
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos